KR20090121358A - 5-ht2c 작용제로서 피리미도 [4,5-d] 아제핀 유도체 - Google Patents
5-ht2c 작용제로서 피리미도 [4,5-d] 아제핀 유도체 Download PDFInfo
- Publication number
- KR20090121358A KR20090121358A KR1020097019789A KR20097019789A KR20090121358A KR 20090121358 A KR20090121358 A KR 20090121358A KR 1020097019789 A KR1020097019789 A KR 1020097019789A KR 20097019789 A KR20097019789 A KR 20097019789A KR 20090121358 A KR20090121358 A KR 20090121358A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- pyrimido
- tetrahydro
- disorder
- benzyl
- Prior art date
Links
- 0 C*(C(C(C(*)(*)C*(*)CC1(C)*)=C1N1)=O)C1=S Chemical compound C*(C(C(C(*)(*)C*(*)CC1(C)*)=C1N1)=O)C1=S 0.000 description 11
- CZWQBSKNHUVZLI-UHFFFAOYSA-N C(c1ccccc1)c1ncc(CCNCC2)c2n1 Chemical compound C(c1ccccc1)c1ncc(CCNCC2)c2n1 CZWQBSKNHUVZLI-UHFFFAOYSA-N 0.000 description 1
- LKEANTDUCXRELW-UHFFFAOYSA-N CC(C)(C)OC(N(CC1)CCC(N=C(C2(CC2)C2=CC=CCC2)N2)=C1C2=O)O Chemical compound CC(C)(C)OC(N(CC1)CCC(N=C(C2(CC2)C2=CC=CCC2)N2)=C1C2=O)O LKEANTDUCXRELW-UHFFFAOYSA-N 0.000 description 1
- OSUDKQMLUGNWPI-CRQQJOEMSA-N CC/C(/NC)=C(\C)/C(/CCN(CC)C(OCC)=O)=N\CCc1ccccc1 Chemical compound CC/C(/NC)=C(\C)/C(/CCN(CC)C(OCC)=O)=N\CCc1ccccc1 OSUDKQMLUGNWPI-CRQQJOEMSA-N 0.000 description 1
- WUGLVOSBZNQBTG-SRZZPIQSSA-N CCC/C(/CN(C)c1nc(CCN(CC2)C(OC(C)(C)C)=O)c2c(N2CCOCC2)n1)=C\CC=C Chemical compound CCC/C(/CN(C)c1nc(CCN(CC2)C(OC(C)(C)C)=O)c2c(N2CCOCC2)n1)=C\CC=C WUGLVOSBZNQBTG-SRZZPIQSSA-N 0.000 description 1
- CZWSQHFWJFVSKY-UHFFFAOYSA-N CCCc1c(CCNC(OC(C)(C)C)=O)c(N2CCOCC2)nc(C2(CC2)c2ccccc2)n1 Chemical compound CCCc1c(CCNC(OC(C)(C)C)=O)c(N2CCOCC2)nc(C2(CC2)c2ccccc2)n1 CZWSQHFWJFVSKY-UHFFFAOYSA-N 0.000 description 1
- SGBGCXQCQVUHNE-UHFFFAOYSA-N CCNC(C)CO Chemical compound CCNC(C)CO SGBGCXQCQVUHNE-UHFFFAOYSA-N 0.000 description 1
- CJGHMRLHUQZAAB-UHFFFAOYSA-N CCOC(N1CCc2nc(Cc3ccccc3)nc(C3CC3)c2CC1)=O Chemical compound CCOC(N1CCc2nc(Cc3ccccc3)nc(C3CC3)c2CC1)=O CJGHMRLHUQZAAB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89652707P | 2007-03-23 | 2007-03-23 | |
US60/896,527 | 2007-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090121358A true KR20090121358A (ko) | 2009-11-25 |
Family
ID=39529327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097019789A KR20090121358A (ko) | 2007-03-23 | 2008-03-14 | 5-ht2c 작용제로서 피리미도 [4,5-d] 아제핀 유도체 |
Country Status (11)
Country | Link |
---|---|
US (1) | US7928099B2 (fr) |
EP (1) | EP2139896A1 (fr) |
JP (1) | JP2010522156A (fr) |
KR (1) | KR20090121358A (fr) |
CN (1) | CN101652367A (fr) |
AU (1) | AU2008231543B2 (fr) |
CA (1) | CA2681536A1 (fr) |
IL (1) | IL200442A0 (fr) |
MX (1) | MX2009010208A (fr) |
WO (1) | WO2008117169A1 (fr) |
ZA (1) | ZA200907416B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2789338A3 (fr) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Dérivé de pyridine condensé et son utilisation |
US8829011B2 (en) | 2008-10-29 | 2014-09-09 | Janssen Pharmaceutica Nv | 2-aminopyrimidine compounds as serotonin receptor modulators |
AR074231A1 (es) * | 2008-11-27 | 2010-12-29 | Boehringer Ingelheim Int | Derivados de 6, 7, 8, 9-tetrahidro-5h-1, 4, 7, 10a-tetraaza-ciclohept[f]indeno, composiciones farmacéuticas que contienen estos compuestos, su uso en el agonismo del receptor 5-ht2c y procesos para prepararlos. |
EP2510949A4 (fr) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | Agent thérapeutique pour la fibromyalgie |
US20130267500A1 (en) | 2010-09-01 | 2013-10-10 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
WO2015066344A1 (fr) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | Agonistes du récepteur 5-ht2c et compositions et procédés d'utilisation |
WO2020072675A1 (fr) | 2018-10-02 | 2020-04-09 | Northwestern University | Bêta-carbolines servant de modulateurs allostériques positifs du récepteur humain de la sérotonine 2c (5-ht2c) |
BR112022019628A2 (pt) * | 2020-04-30 | 2022-11-16 | Raqualia Pharma Inc | Composto da fórmula (i), enantiômero único, composição farmacêutica, processo para a preparação desta, método para o tratamento de uma condição ou distúrbio mediado pela atividade antagonista do receptor de trpv4 em um animal incluindo um humano, uso de um composto e composto representado pela fórmula (i-d) |
CN113636977B (zh) * | 2021-09-01 | 2022-12-20 | 温州大学 | 2-芳基苯并氮杂卓及其衍生物的合成方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US32481A (en) * | 1861-06-04 | Tent-fixture | ||
US225275A (en) * | 1880-03-09 | Seed-planter | ||
US5043443A (en) * | 1988-07-29 | 1991-08-27 | Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives |
WO2003104230A1 (fr) * | 2002-06-07 | 2003-12-18 | 協和醱酵工業株式会社 | Derives bicycliques de pyrimidine |
US20040115804A1 (en) * | 2002-12-13 | 2004-06-17 | Yu-Show Fu | Cell system for generating somatic cells |
WO2006044762A2 (fr) | 2004-10-15 | 2006-04-27 | Bayer Pharmaceuticals Corporation | Derives tetrahydro-5h-pyrimido[4,5-d]azepine convenant pour le traitement de maladies associees au recepteur 5-ht2c |
AU2006278759B2 (en) | 2005-08-04 | 2012-08-16 | Janssen Pharmaceutica N.V. | Pyrimidine compounds as serotonin receptor modulators |
US7598255B2 (en) * | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
US20080051387A1 (en) | 2006-06-09 | 2008-02-28 | Yuelian Xu | Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
-
2008
- 2008-03-14 EP EP08719376A patent/EP2139896A1/fr not_active Withdrawn
- 2008-03-14 WO PCT/IB2008/000731 patent/WO2008117169A1/fr active Application Filing
- 2008-03-14 JP JP2009554097A patent/JP2010522156A/ja not_active Withdrawn
- 2008-03-14 US US12/532,715 patent/US7928099B2/en not_active Expired - Fee Related
- 2008-03-14 AU AU2008231543A patent/AU2008231543B2/en not_active Ceased
- 2008-03-14 KR KR1020097019789A patent/KR20090121358A/ko active IP Right Grant
- 2008-03-14 MX MX2009010208A patent/MX2009010208A/es active IP Right Grant
- 2008-03-14 CN CN200880009524A patent/CN101652367A/zh active Pending
- 2008-03-14 CA CA002681536A patent/CA2681536A1/fr not_active Abandoned
-
2009
- 2009-08-17 IL IL200442A patent/IL200442A0/en unknown
- 2009-10-22 ZA ZA200907416A patent/ZA200907416B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2139896A1 (fr) | 2010-01-06 |
IL200442A0 (en) | 2010-04-29 |
CN101652367A (zh) | 2010-02-17 |
JP2010522156A (ja) | 2010-07-01 |
AU2008231543A1 (en) | 2008-10-02 |
US7928099B2 (en) | 2011-04-19 |
WO2008117169A1 (fr) | 2008-10-02 |
US20100113422A1 (en) | 2010-05-06 |
AU2008231543B2 (en) | 2011-07-28 |
ZA200907416B (en) | 2010-07-28 |
CA2681536A1 (fr) | 2008-10-02 |
MX2009010208A (es) | 2009-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4318744B2 (ja) | シクロペンタピリジンおよびテトラヒドロキノリン誘導体 | |
KR20090121358A (ko) | 5-ht2c 작용제로서 피리미도 [4,5-d] 아제핀 유도체 | |
US6800627B1 (en) | Pirazino indole derivatives | |
KR100566854B1 (ko) | 5-ht 수용체 리간드 및 그의 용도 | |
CN106661002B (zh) | 用于治疗炎性、代谢性、肿瘤性和自身免疫性疾病的嘧啶衍生物 | |
ES2391374T3 (es) | Alquilciclohexiléteres de dihidrotetraazabenzoazulenos | |
JP2004517852A (ja) | インドール誘導体および5−ht2bおよび5−ht2c受容体リガンドとしてのそれらの使用 | |
JP2008531679A (ja) | オキシトシンアンタゴニストとしての1,2,4−トリアゾール誘導体とその使用 | |
CA2570046A1 (fr) | Derives triazole substitues utilises en tant qu'antagonistes de l'oxytocine | |
JP2002541258A (ja) | インターリューキン−12シグナルを阻害するための治療用化合物及びその使用方法 | |
JP2003160508A (ja) | 成長ホルモン分泌促進薬を含む治療方法及びキット | |
JP2008150371A (ja) | 性機能障害を治療するための化合物 | |
JP2006525309A (ja) | ピロロ(1,2−b)ピリダジン化合物、ならびにCRF−1受容体拮抗薬としてのその使用 | |
JP2006511530A (ja) | カルバゾール誘導体およびnpy−5アンタゴニストとしてのその使用 | |
JP2006511529A (ja) | Npy−5アンタゴニストとしての5−アミノフェナンスリジン誘導体 | |
TW200413380A (en) | Pyrrolo[1, 2-B]pyridazine compounds and their uses | |
JP2003012626A (ja) | アルキルアミド化合物 | |
US20070219220A1 (en) | Pyrazolopyrimidinethione Derivatives, Salts and Solvates Thereof, Preparation Methods and Use Thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |